SEC Form 4 · accession 0001209191-18-038661
Eloxx Pharmaceuticals, Inc. · ELOX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
Pontifax (Cayman) III, L.P.
10% Owner
Pontifax (Israel) III, L.P.
10% Owner
Pontifax Management Fund III L.P.
10% Owner
Period of report
Jun 15, 2018
Accepted (ET)
Jun 19, 2018 · 6:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001035354
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2,F1 | $23.27 | Jun 15, 2018 | A | 40,000 | A | — | Jun 15, 2028 | Common Stock | 40,000 | 40,000 | I |
| Stock Option (Right to Buy)F3,F1 | $23.27 | Jun 15, 2018 | A | 40,000 | A | — | Jun 15, 2028 | Common Stock | 40,000 | 40,000 | I |
Explanation of responses
- F1One half (1/2) of the shares underlying the option shall vest on June 15, 2019 (the "Cliff Vesting Date"), the remainder of the grant shall vest in equal installments on each successive monthly anniversary of the Cliff Vesting Date, subject to Reporting Person's continuous service as of each such date.
- F2The reported securities are owned directly by Tomer Kariv, a general partner of Pontifax Management III G.P. (2011) Ltd. ("Pontifax 3"). Mr. Kariv will assign the economic interests of the reported securities to Pontifax 3 and it may be deemed the indirect beneficial owner of the security. Pontifax 3 disclaims beneficial ownership of the security except to the extent of its pecuniary interest therein.
- F3The reported securities are owned directly by Ran Nussbaum, a general partner of Pontifax 3. Mr. Nussbaum will assign the economic interests of the reported securities to Pontifax 3 and it may be deemed the indirect beneficial owner of the security. Pontifax 3 disclaims beneficial ownership of the security except to the extent of its pecuniary interest therein.